{"id":45183,"date":"2022-06-16T20:01:32","date_gmt":"2022-06-16T18:01:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/"},"modified":"2022-06-16T20:01:32","modified_gmt":"2022-06-16T18:01:32","slug":"diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/","title":{"rendered":"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>After rigorous peer review by DRC\u2019s Scientific Review Committee, eight early-career researchers were awarded seed funding for their work to find the cause, treatment, and cure for T1D<\/i>\n<\/p>\n<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/DRC?src=hash\" target=\"_blank\" rel=\"noopener\">#DRC<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.diabetesresearchconnection.org&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Diabetes+Research+Connection&amp;index=1&amp;md5=80644cc1d0da9a0527560d19bbde196a\" rel=\"nofollow noopener\" shape=\"rect\">Diabetes Research Connection<\/a> (DRC), a 501(c)(3) that funds <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2F%23successfullyfundedd561-cf47abaf-3536&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=research+projects&amp;index=2&amp;md5=81d67bc5db08885c5096f3c01721f360\" rel=\"nofollow noopener\" shape=\"rect\">research projects<\/a> conducted by early-career researchers aimed at prevention, cure, and better care for those with Type 1 Diabetes (T1D), recently awarded seed funding to eight promising new T1D studies totaling a $400,000 investment, as it celebrates 10 years advancing diabetes research. The process of distributing the awards is underway.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220616005854\/en\/1489432\/4\/Picture1.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220616005854\/en\/1489432\/21\/Picture1.jpg\"><\/a><\/p>\n<p>\nDRC announces awards twice annually after its <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fabout-us%2Fscientific-review-committee-2%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Scientific+Review+Committee&amp;index=3&amp;md5=66329f67d6e3c951803212d47463c991\" rel=\"nofollow noopener\" shape=\"rect\">Scientific Review Committee<\/a> (SRC), comprised of T1D experts nationwide, conducts rigorous review of dozens of applications from researchers at renowned institutions and universities.\n<\/p>\n<p>\nJune 2022 DRC funding recipients include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Rehana Akter, Ph.D. \u2013 University of Washington<br \/>\n<br \/><\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2Fcholesterol-exacerbating-t1d%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Is+Cholesterol+Exacerbating+T1D+by+Reducing+the+Functionality+and+Regeneration+Ability+of+Residual+Beta+Cells%3F&amp;index=4&amp;md5=d897080fa744f81c09cc6a45f01b8bc7\" rel=\"nofollow noopener\" shape=\"rect\">Is Cholesterol Exacerbating T1D by Reducing the Functionality and Regeneration Ability of Residual Beta Cells?<\/a>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Jennifer Dwyer, Ph.D. \u2013 The Jackson Laboratory<br \/>\n<br \/><\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2Flethal-category-of-cells%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Taming+a+Particularly+Lethal+Category+of+Cells+May+Reduce%2FEliminate+the+Onset+of+T1D&amp;index=5&amp;md5=d46995c421110509591ba4328269ee72\" rel=\"nofollow noopener\" shape=\"rect\">Taming a Particularly Lethal Category of Cells May Reduce\/Eliminate the Onset of T1D<\/a>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Leonardo Ferreira, Ph.D. \u2013 Medical University of South Carolina<br \/>\n<br \/><\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2Fre-educating-the-patients-immune-system%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=A+Potential+Second+Cure+for+T1D+by+Re-Educating+the+Patient%26%238217%3Bs+Immune+System&amp;index=6&amp;md5=dd7a2edcf6e58cb3828f9aa4f1556a3f\" rel=\"nofollow noopener\" shape=\"rect\">A Potential Second Cure for T1D by Re-Educating the Patient\u2019s Immune System<\/a>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Sandra Mara Ferreira, Ph.D. \u2013 University of Florida<br \/>\n<br \/><\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2Fpancreatic-molecule-gaba%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Understanding+How+a+Pancreatic+Molecule+%28GABA%29+Works+May+Lead+to+a+New+Treatment+for+T1+and+T2+Diabetes&amp;index=7&amp;md5=e7532e239299127987b411e6be5aa81d\" rel=\"nofollow noopener\" shape=\"rect\">Understanding How a Pancreatic Molecule (GABA) Works May Lead to a New Treatment for T1 and T2 Diabetes<\/a>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Anna Kahkoska, M.D., Ph.D. \u2013 University of North Carolina at Chapel Hill<br \/>\n<br \/><\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2Fhealthy-aging-with-t1d%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Stakeholder-Engaged+Precision+Health+for+Longevity+and+Healthy+Aging+with+Type+1+Diabetes&amp;index=8&amp;md5=38ec95315162854324668a9868c77cc0\" rel=\"nofollow noopener\" shape=\"rect\">Stakeholder-Engaged Precision Health for Longevity and Healthy Aging with Type 1 Diabetes<\/a>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Melanie Shapiro, Ph.D. \u2013 University of Florida<br \/>\n<br \/><\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2Fspecific-body-gene%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Can+the+Inhibition+of+One+Specific+Body+Gene+Prevent+Type+1+Diabetes%3F&amp;index=9&amp;md5=e19eacab3f905b54c94f2556a4909504\" rel=\"nofollow noopener\" shape=\"rect\">Can the Inhibition of One Specific Body Gene Prevent Type 1 Diabetes?<\/a>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Xin Tong, Ph.D. \u2013 Vanderbilt University<br \/>\n<br \/><\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2Fdysfunctionality-of-two-pancreatic-cells%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=A+call+to+question%26%238230%3BIs+T1D+Caused+by+Dysfunctionality+of+Two+Pancreatic+Cells+%28%26%23946%3B+and+%26%23945%3B%29%3F&amp;index=10&amp;md5=b9b5313569953033a101004fd14a0b41\" rel=\"nofollow noopener\" shape=\"rect\">A call to question\u2026Is T1D Caused by Dysfunctionality of Two Pancreatic Cells (\u03b2 and \u03b1)?<\/a>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Han Zhu, Ph.D. \u2013 University of California, San Diego<br \/>\n<br \/><\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2Feliminating-the-rejection-of-cells%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Validating+the+Hypothesis+to+Cure+T1D+by+Eliminating+the+Rejection+of+Cells+from+Another+Person+by+Farming+Beta-Cells+from+a+Patient%26%238217%3Bs+Own+Stem+Cells&amp;index=11&amp;md5=8b13cd8a70fa9deadff47ca9d8f5b95c\" rel=\"nofollow noopener\" shape=\"rect\">Validating the Hypothesis to Cure T1D by Eliminating the Rejection of Cells from Another Person by Farming Beta-Cells from a Patient\u2019s Own Stem Cells<\/a>\n<\/li>\n<\/ul>\n<p>\nOne researcher among the eight awarded DRC funding, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2Flethal-category-of-cells%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Dr.+Jennifer+Dwyer+of+The+Jackson+Laboratory&amp;index=12&amp;md5=79d1e205ab689773e2fb127f6b9133b0\" rel=\"nofollow noopener\" shape=\"rect\">Dr. Jennifer Dwyer of The Jackson Laboratory<\/a>,<b> <\/b>says, \u201cTwo years after I earned my Ph.D., my son was diagnosed with T1D. Knowing how this impacted his metabolism, I took a break from work to care for my young family. During this time away from the bench, I got to know the inspiring T1D community through my son&#8217;s physicians, networking with other T1D families, and reading scientific literature. Artificial pancreas technology is wonderful, but it is not enough; we can do better. In deciding to return to science, I wanted to work on something I cared deeply for.\u201d\n<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fabout-us%2Fboard-of-directors%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=Alberto+Hayek%2C+M.D.&amp;index=13&amp;md5=bf2a8702013fbe6cc7eabfb3ccaa1d48\" rel=\"nofollow noopener\" shape=\"rect\">Alberto Hayek, M.D.<\/a>, renowned diabetes expert, former Scientific Director at San Diego\u2019s Scripps Whittier Institute for Diabetes, Professor Emeritus of Pediatrics at UCSD, DRC board member and co-founder says, \u201cDRC continues to provide seed funding to promising T1D research conducted by innovative early-career scientists across the U.S. The eight talented researchers we selected in one of two funding phases in 2022 are exploring exciting leads as to the cause and prevention of T1D and how we might ultimately cure the disease. These types of early-stage studies are often overlooked by other funding sources yet have potential to forever influence our understanding of T1D.\u201d\n<\/p>\n<p>\nU.S.-based post-doctoral fellows, professors, and instructors whose research is focused on T1D and have not received NIH funding as a Principal Investigator, are eligible to <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fsubmit-a-project%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=apply+for+DRC+funding&amp;index=14&amp;md5=883b59271d3b2c6ad92c270dffa94ec9\" rel=\"nofollow noopener\" shape=\"rect\">apply for DRC funding<\/a>. Once a study has been approved by DRC\u2019s SRC, donors have the opportunity to <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdiabetesresearchconnection.org%2Fprojects%2F&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=support+a+research+project&amp;index=15&amp;md5=03bf93f7d7355ae4ed41baad7220d952\" rel=\"nofollow noopener\" shape=\"rect\">support a research project<\/a> of their choice, interact with researchers, receive project updates and personalized thank-you letters, and attend in-person events with researchers.<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.DiabetesResearchConnection.com&amp;esheet=52752335&amp;newsitemid=20220616005854&amp;lan=en-US&amp;anchor=www.DiabetesResearchConnection.com&amp;index=16&amp;md5=286fc19fd37fe0aea9a3162831abb759\" rel=\"nofollow noopener\" shape=\"rect\"> www.DiabetesResearchConnection.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nHilary McCarthy<br \/>\n<br \/><a target=\"_blank\" href=\"mailto:Hilar&#121;&#64;&#99;&#108;&#101;&#97;&#114;&#112;&#111;&#105;&#110;&#116;&#97;&#103;&#101;&#x6e;&#x63;&#x79;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x48;&#x69;&#x6c;&#x61;&#x72;&#x79;&#x40;&#x63;&#x6c;&#x65;&#x61;&#x72;&#x70;&#x6f;&#x69;&#x6e;&#x74;&#x61;&#x67;&#x65;&#x6e;&#x63;&#x79;&#x2e;&#x63;&#x6f;&#x6d;<\/a><br \/>774-364-1440\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>After rigorous peer review by DRC\u2019s Scientific Review Committee, eight early-career researchers were awarded seed funding for their work to find the cause, treatment, and cure for T1D SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#DRC&#8212;Diabetes Research Connection (DRC), a 501(c)(3) that funds research projects conducted by early-career researchers aimed at prevention, cure, and better care for those with Type &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45183","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"After rigorous peer review by DRC\u2019s Scientific Review Committee, eight early-career researchers were awarded seed funding for their work to find the cause, treatment, and cure for T1D SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#DRC&#8212;Diabetes Research Connection (DRC), a 501(c)(3) that funds research projects conducted by early-career researchers aimed at prevention, cure, and better care for those with Type ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-16T18:01:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220616005854\/en\/1489432\/21\/Picture1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies\",\"datePublished\":\"2022-06-16T18:01:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/\"},\"wordCount\":629,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005854\\\/en\\\/1489432\\\/21\\\/Picture1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/\",\"name\":\"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005854\\\/en\\\/1489432\\\/21\\\/Picture1.jpg\",\"datePublished\":\"2022-06-16T18:01:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005854\\\/en\\\/1489432\\\/21\\\/Picture1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220616005854\\\/en\\\/1489432\\\/21\\\/Picture1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/","og_locale":"en_US","og_type":"article","og_title":"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies - Pharma Trend","og_description":"After rigorous peer review by DRC\u2019s Scientific Review Committee, eight early-career researchers were awarded seed funding for their work to find the cause, treatment, and cure for T1D SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;#DRC&#8212;Diabetes Research Connection (DRC), a 501(c)(3) that funds research projects conducted by early-career researchers aimed at prevention, cure, and better care for those with Type ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-16T18:01:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220616005854\/en\/1489432\/21\/Picture1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies","datePublished":"2022-06-16T18:01:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/"},"wordCount":629,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220616005854\/en\/1489432\/21\/Picture1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/","url":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/","name":"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220616005854\/en\/1489432\/21\/Picture1.jpg","datePublished":"2022-06-16T18:01:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220616005854\/en\/1489432\/21\/Picture1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220616005854\/en\/1489432\/21\/Picture1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/diabetes-research-connection-awards-400000-to-eight-promising-t1d-studies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Diabetes Research Connection Awards $400,000 to Eight Promising T1D Studies"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45183"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45183\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}